EX-1
from SCHEDULE 13D/A
~5
pages
February 3, 2025 via Certified Mail via Registered Agent Aadi Bioscience, Inc. Aadi Bioscience, Inc. Attn: Board of Directors C/O the Corporation Trust Company 17383 Sunset Boulevard, Suite A250 1209 Orange Street Pacific Palisades, Ca 90272 Wilmington, De 19801 Re: Demand for Inspection of Books and Records Dear Board of Directors: We Represent BML Investment Partners, L.P. (“Stockholder”), a Stockholder of Aadi Bioscience, Inc. (The “Company” or “Aadi”). This Letter Is Stockholder’s Demand to Inspect Certain Books and Records of the Company (The “Demand”) Pursuant to 8 Del. C. § 220 (“Section 220”) Relating to the Aadi’s Decision to Pass Up a Favorable Sale of the Company in Favor of a Dilutive, Discounted, and Conflicted Financing Agreement and the Sale of Its Main Asset, While Preserving Managements’ Employment and Compensation. Evidence of Stockholder’s Continuous Stock Ownership Is Attached Hereto as Exhibit 1. a Power of Attorney Appointing Morris Kandinov Llp to Act on Behalf Of
12/34/56
